Patel Naimish bought CRSP
March 14, 2025 · Form 4 insider transaction
Patel Naimish bought 32,500 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,500
Price
$0.00
Total value
N/A
InsiderPatel Naimish
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 14, 2025
Filing dateMarch 18, 2025
Shares owned after32,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.; This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.